Abstract Library

#2000 A Case of Multiple Endocrine Neoplasia Type 2B（MEN2B）

Introduction: Familial neuroendocrine neoplasms (NENs) accounts for less than 5% of NENs and multiple endocrine neoplasia type 2B (MEN2B) is a kind of rare familial NENs.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Zhang Y

Authors: Zhang Y, Chen L, Chen M, Chen J,

Keywords: multiple endocrine neoplasia type 2B, medullary thyroid carcinoma, diagnosis, treatment,

#1664 The Clinicopathological Characteristics and Prognosis of Rectal Neuroendocrine Neoplasms: A Multicenter Retrospective Study from China

Introduction: Rectum is one of the most common primary sites of neuroendocrine neoplasms (NEN). But few studies from China with large sample investigated the clinicopathological characteristics of rectal NEN.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Chen L

Authors: Chen L, Peng X, Jin K, Zhang Y, Chen M,

Keywords: rectum, neuroendocrine neoplasm, clinicopathological features, prognosis,

#1662 Two Separate Modified ENETS Staging Classifications Are Needed for Duodenal and Jejunoileal Neuroendocrine Neoplasms

Introduction: Previous studies showed duodenal neuroendocrine neoplasms (d-NEN) and jejunoileal NEN (j-NEN) harboring different features. However, the staging classifications of d-NEN and j-NEN proposed by ENETS are identical.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Chen L

Authors: Chen L, Zhang Y, Chen M, Chen J,

Keywords: stage, duodenum, jejunoileum, neuroendocrine neoplasms,

#1658 The Clinical Significance of Elevated Serum Procalcitonin in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms

Introduction: Elevated serum procalcitonin (PCT) was reported in some patients with neuroendocrine neoplasms (NEN), but its clinical significance in gastroenteropancreatic NEN (GEP-NEN) was still unknown.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Chen L

Authors: Chen L, Zhang Y, Chen M, Chen J,

Keywords: procalcitonin, neuroendocrine neoplasms, tumor grade, survival,

#1454 Everolimus in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Neoplasm: A Single-Center Retrospective Study in China

Introduction: Everolimus showed antitumor activity in patients with advanced pancreatic neuroendocrine tumors in a phase III clinical trial, but data in Chinese patients was limited.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Chen J

Authors: Zhang Y, Chen L, Chen M, Chen J,

Keywords: gastroenteropancreatic neuroendocrine neoplasm,everolimus, treatment,